S. Roemer Alan's most recent trade in IN8bio Inc was a trade of 63,150 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| IN8bio Inc | Alan S. Roemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 63,150 | 63,150 | - | - | Stock Option (right to buy) | |
| IN8bio Inc | Alan S. Roemer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.18 per share. | 27 Apr 2025 | 102,459 | 387,489 | - | 0.2 | 18,893 | Common Stock |
| IN8bio Inc | Alan S. Roemer | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Apr 2025 | 102,459 | 0 | - | - | Series B Warrants (right to buy) | |
| IN8bio Inc | Alan S. Roemer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2025 | 102,459 | 0 | - | - | Series A Warrants (right to buy) | |
| IN8bio Inc | Alan S. Roemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2025 | 102,459 | 102,459 | - | - | Series A Warrants (right to buy) | |
| IN8bio Inc | Alan S. Roemer | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Apr 2025 | 102,459 | 0 | - | - | Series A Warrants (right to buy) | |
| IN8bio Inc | Alan S. Roemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2025 | 91,459 | 91,459 | - | - | Series B Warrants (right to buy) | |
| IN8bio Inc | Alan S. Roemer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2025 | 11,000 | 0 | - | - | Series B Warrants (right to buy) | |
| IN8bio Inc | Alan S. Roemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2025 | 11,000 | 11,000 | - | - | Series B Warrants (right to buy) | |
| IN8bio Inc | Alan S. Roemer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.18 per share. | 27 Apr 2025 | 11,000 | 398,489 | - | 0.2 | 2,028 | Common Stock |
| IN8bio Inc | S. Roemer Alan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 93,242 | 93,242 | - | - | Stock Option (right to buy) | |
| IN8bio Inc | Alan S. Roemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 126,582 | 126,582 | - | - | Series C Warrants (right to buy) | |
| IN8bio Inc | Alan S. Roemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 126,582 | 285,030 | - | - | Common Stock | |
| IN8bio Inc | Alan S. Roemer | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 102,459 | 0 | - | - | Series A Warrants (right to buy) | |
| IN8bio Inc | Alan S. Roemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 102,459 | 102,459 | - | - | Series A Warrants (right to buy) | |
| IN8bio Inc | Alan S. Roemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 33,650 | 33,650 | - | - | Stock Option (right to buy) | |
| IN8bio Inc | Alan Roemer S. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 102,459 | 102,459 | - | - | Series A Warrants (right to buy) | |
| IN8bio Inc | Roemer Alan S. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 102,459 | 158,448 | - | - | Common Stock | |
| IN8bio Inc | S. Roemer Alan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 102,459 | 102,459 | - | - | Series B Warrants (right to buy) | |
| Neximmune Inc | Alan S. Roemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2023 | 44,983 | 44,983 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Alan S. Roemer | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 61,678 | 0 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Alan S. Roemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 61,678 | 61,678 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Alan S. Roemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 23,122 | 23,122 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Alan S. Roemer | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 23,122 | 0 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Alan S. Roemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 9,556 | 9,556 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Alan S. Roemer | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 9,556 | 0 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Alan S. Roemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 3,856 | 3,856 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Alan S. Roemer | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Apr 2023 | 3,856 | 0 | - | - | Stock Option (right to buy) | |
| IN8bio Inc | Alan S. Roemer | Director | Purchase of securities on an exchange or from another person at price $ 1.90 per share. | 16 Aug 2022 | 26,315 | 55,989 | - | 1.9 | 49,999 | Common Stock |
| Neximmune Inc | Alan S. Roemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 61,678 | 61,678 | - | - | Stock Option (Right to Buy) | |
| IN8bio Inc | Alan S. Roemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 13,500 | 13,500 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Alan S. Roemer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.31 per share. | 21 Dec 2021 | 42,389 | 195,641 | - | 4.3 | 182,697 | Common Stock |
| Neximmune Inc | Alan S. Roemer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2021 | 42,389 | 3,856 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Alan S. Roemer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.58 per share. | 21 Dec 2021 | 12,634 | 153,252 | - | 2.6 | 32,596 | Common Stock |
| Neximmune Inc | Alan S. Roemer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.42 per share. | 21 Dec 2021 | 12,634 | 140,618 | - | 2.4 | 30,574 | Common Stock |
| Neximmune Inc | Alan S. Roemer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2021 | 12,634 | 0 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Alan S. Roemer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2021 | 12,634 | 0 | - | - | Stock Option (right to buy) | |
| IN8bio Inc | Alan S. Roemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 86,258 | 86,258 | - | - | Stock Option (right to buy) | |
| IN8bio Inc | Alan S. Roemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2021 | 10,500 | 10,500 | - | - | Stock Option (right to buy) | |
| Neximmune Inc | Alan S. Roemer | Director | 17 Feb 2021 | 85,016 | 0 | - | - | Series A Preferred Stock | ||
| Neximmune Inc | Alan S. Roemer | Director | 17 Feb 2021 | 85,016 | 85,016 | - | - | Common Stock | ||
| Neximmune Inc | Alan S. Roemer | Director | 17 Feb 2021 | 26,590 | 115,716 | - | - | Common Stock | ||
| Neximmune Inc | Alan S. Roemer | Director | 17 Feb 2021 | 26,590 | 0 | - | - | Series A3 Preferred Stock | ||
| Neximmune Inc | Alan S. Roemer | Director | 17 Feb 2021 | 12,268 | 127,984 | - | - | Common Stock | ||
| Neximmune Inc | Alan S. Roemer | Director | 17 Feb 2021 | 4,110 | 0 | - | - | Series A2 Preferred Stock | ||
| Neximmune Inc | Alan S. Roemer | Director | 17 Feb 2021 | 4,110 | 89,126 | - | - | Common Stock | ||
| Neximmune Inc | Alan S. Roemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 9,556 | 104,191 | - | - | Stock Option (right to buy) |